Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal corticotropin-releasing factor

Neuroscience

Volumn 123, Issue 3, 2004, Pages 589-594

  Kozicz, T ^a   Korosi, A ^a   Korsman, C ^a   Tilburg Ouwens, D ^a   Groenink, L ^b   Veening, J ^c   Van Der Gugten, J ^b   Roubos, E ^a   Olivier, B ^b,d  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute ether stress; In situ hybridization; Quantitative Fos immunohistochemistry

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; UROCORTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOHISTOCHEMISTRY; MAJOR DEPRESSION; MALE; MOUSE; NERVOUS SYSTEM; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0347360185     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.10.042     Document Type: Article

References (28)

1. Arato M., Banki C.M., Bissette G., Nemeroff C.B. Elevated CSF CRF in suicide victims. Biol Psychiatry. 25:1989;355-359.
2. Bale T.L., Contarino A., Smith G.W., Chan R., Gold L.H., Sawchenko P.E., Koob G.F., Vale W.W., Lee K.F. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress. Nat Genet. 24:2000;410-414.
3. Bittencourt J.C., Vaughan J., Arias C., Rissman R.A., Vale W.W., Sawchenko P.E. Urocortin expression in rat brain evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors . J Comp Neurol. 415:1999;285-312.
4. Coste S.C., Kesterson R.A., Heldwein K.A., Stevens S.L., Heard A.D., Hollis J.H., Murray S.E., Hill J.K., Pantely G.A., Hohimer A.R., Hatton D.C., Phillips T.J., Finn D.A., Low M.J., Rittenberg M.B., Stenzel P., Stenzel-Poore M.P. Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nat Genet. 24:2000;403-409.
5. Coste S.C., Murray S.E., Stenzel-Poore M.P. Animal models of CRH excess and CRH receptor deficiency display altered adaptations to stress. Peptides. 22:2001;733-741.
6. Dirks A., Groenink L., Bouwknecht J.A., Hijzen T.H., van der G.J., Ronken E., Verbeek J.S., Veening J.G., Dederen P.J., Korosi A., Schoolderman L.F., Roubos E.W., Olivier B. Overexpression of corticotropin-releasing hormone in transgenic mice and chronic stress-like autonomic and physiological alterations. Eur J Neurosci. 16:2002;1751-1760.
7. Floderus S. Untersuchungen über den Bau der menschlichen Hypophyse mit besonderer Berücksichtigung der quantitativen mikromorphologische Verhältnisse. Acta Pathol Microbiol Scand. 53:1944;276.
8. Fossey M.D., Lydiard R.B., Ballenger J.C., Laraia M.T., Bissette G., Nemeroff C.B. Cerebrospinal fluid corticotropin-releasing factor concentrations in patients with anxiety disorders and normal comparison subjects. Biol Psychiatry. 39:1996;703-707.
9. Groenink L., Pattij T., De Jongh R., van der G.J., Oosting R.S., Dirks A., Olivier B. 5-HT(1A) receptor knockout mice and mice overexpressing corticotropin-releasing hormone in models of anxiety. Eur J Pharmacol. 463:2003;185-197.
10. Hsu S.Y., Hsueh A.J. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med. 7:2001;605-611.
11. Jones D.N., Kortekaas R., Slade P.D., Middlemiss D.N., Hagan J.J. The behavioural effects of corticotropin-releasing factor-related peptides in rats. Psychopharmacology (Berl). 138:1998;124-132.
12. Klooster J., Beckers H.J., Vrensen G.F., van der Want J.J. The peripheral and central projections of the Edinger-Westphal nucleus in the rat a light and electron microscopic tracing study . Brain Res. 632:1993;260-273.
13. Kozicz, T, Gaszner, B, Arimura, A (2001a) The activation of urocortin immunoreactive neurons in the Edinger-Westphal nucleus following various acute stressors. Society for Neuroscience 31st Annual Meeting, San Diego, California, USA. 414.12. Abstract.
14. Kozicz T., Min L., Arimura A. The activation of urocortin immunoreactive neurons in the Edinger-Westphal nucleus following acute pain stress in rats. Stress. 4:2001;85-90.
15. Kozicz T., Yanaihara H., Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol. 391:1998;1-10.
16. Lewis K., Li C., Perrin M.H., Blount A., Kunitake K., Donaldson C., Vaughan J., Reyes T.M., Gulyas J., Fischer W., Bilezikjian L., Rivier J., Sawchenko P.E., Vale W.W. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA. 98:2001;7570-7575.
17. Plotsky P.M., Owens M.J., Nemeroff C.B. Psychoneuroendocrinology of depression hypothalamic-pituitary-adrenal axis . Psychiatr Clin North Am. 21:1998;293-307.
18. Raadsheer F.C., Hoogendijk W.J., Stam F.C., Tilders F.J., Swaab D.F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Neuroendocrinology. 60:1994;436-444.
19. Reyes T.M., Lewis K., Perrin M.H., Kunitake K.S., Vaughan J., Arias C.A., Hogenesch J.B., Gulyas J., Rivier J., Vale W.W., Sawchenko P.E. Urocortin II a member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors . Proc Natl Acad Sci USA. 98:2001;2843-2848.
20. Sajdyk T.J., Schober D.A., Gehlert D.R., Shekhar A. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res. 100:1999;207-215.
21. Skelton K.H. Chronic administration of the triazolobenzodiazepine alprazolam produces opposite effects on corticotropin-releasing factor and urocortin neuronal systems. J Neurosci. 20:2000;1240-1248.
22. Skelton K.H., Owens M.J., Nemeroff C.B. The neurobiology of urocortin. Regul Pept. 93:2000;85-92.
23. Stenzel-Poore M.P., Heinrichs S.C., Rivest S., Koob G.F., Vale W.W. Overproduction of corticotropin-releasing factor in transgenic mice a genetic model of anxiogenic behavior . J Neurosci. 14:1994;2579-2584.
24. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature. 378:1995;287-292.
25. Vetter D.E., Li C., Zhao L., Contarino A., Liberman M.C., Smith G.W., Marchuk Y., Koob G.F., Heinemann S.F., Vale W., Lee K.F. Urocortin-deficient mice show hearing impairment and increased anxiety-like behavior. Nat Genet. 4:2002;363-369.
26. Weninger S.C., Dunn A.J., Muglia L.J., Dikkes P., Miczek K.A., Swiergiel A.H., Berridge C.W., Majzoub J.A. Stress-induced behaviors require the corticotropin-releasing hormone (CRH) receptor, but not CRH. Proc Natl Acad Sci USA. 96:1999;8283-8288.
27. Weninger S.C., Peters L.L., Majzoub J.A. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency. Endocrinology. 141:2000;256-263.
28. Westphal C. Über einem Fall von chronischer progressive Lahmung des Augenmuskeln (Ophthalmoplegia externa) nebst Beschreibung von Ganglienzellengruppen in Bereich des Oculomotoriuskerns. Arch Psychiatrie Nervenheilkunde. 98:1887;846-871.